Company Description

Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States.

The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer.

It develops SimpleScreen™ CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers.

The company was founded in 2014 and is headquartered in Brisbane, California.

Freenome, Inc.

Country	United States
Founded	2014
Industry	Diagnostics & Research
Sector	Healthcare
Employees	381
CEO	Aaron Elliott

Contact Details

Address: 3300 Marina Boulevard Brisbane, California 94005 United States
Phone	(650) 446-6630
Website	freenome.com

Stock Details

Ticker Symbol	FRNM
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0002017526
CUSIP Number	35661P100
ISIN Number	US35661P1003

Key Executives

Name	Position
Aaron Elliott Ph.D.	Chief Executive Officer and Director
Riley Ennis	Co-Founder and Chief Product Officer
Linh H. Le	Chief Financial Officer
Cheng-Ho Lin M.D., MHS, Ph.D.	Chief Scientific Officer
Thomas F. Fitzpatrick J.D.	Chief Legal Officer
Julie Tran M.B.A., MSHR	Chief People Officer
Sally Howard J.D.	Senior Vice President of Regulatory and Quality
Robert Guigley	Chief Commercial Officer